News & Events IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR News & Events Press Releases Nov 21, 2023 Ardelyx, Inc. Reports Employment Inducement Grants Read More Nov 21, 2023 Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference Read More Nov 15, 2023 XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia Read More View All Press Releases Events & Presentations Nov 29, 2023 at 2:30 PM EST 2023 Piper Sandler Healthcare Conference Nov 16, 2023 at 3:30 AM EST Jefferies London Healthcare Conference Oct 31, 2023 at 8:00 AM EDT Ardelyx Q3 2023 Earnings Call View All Events FAQs Email Alerts Connect
News & Events Press Releases Nov 21, 2023 Ardelyx, Inc. Reports Employment Inducement Grants Read More Nov 21, 2023 Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference Read More Nov 15, 2023 XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia Read More View All Press Releases Events & Presentations Nov 29, 2023 at 2:30 PM EST 2023 Piper Sandler Healthcare Conference Nov 16, 2023 at 3:30 AM EST Jefferies London Healthcare Conference Oct 31, 2023 at 8:00 AM EDT Ardelyx Q3 2023 Earnings Call View All Events
Nov 15, 2023 XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia Read More